Safety and Effectiveness of Ocrelizumab under Real World Conditions: a Non-Interventional Post Authorization Safety Study in Patients Diagnosed with Relapsing or Primary Progressive Multiple Sclerosis (CONFIDENCE)

06/03/2018
10/09/2024
EU PAS number:
EUPAS22951
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

ML39632_NI-PASS Confidence fv1.0_2018-01-26_Redacted

English (1.02 MB - PDF) View document
Updated protocol

ML39632_CONFIDENCE_Protocol_V6.0_Redacted.pdf

First published: 10/09/2024
English (2.37 MB - PDF) View document
Study results
Study report
Other information